Join the club for FREE to access the whole archive and other member benefits.

Amber Tong

Editor at Endpoints News

Her coverage varies daily but as a Hong Kong native, she is particularly excited about drug development in China. A graduate of Rice University, her work has appeared in Houstonia Magazine, Governing Magazine and The Chautauquan Daily. Amber is based in Hong Kong.

 amber-pak-wei-tong-5aa385bb

 AmberTongPW

See also

Endpoints News

News provider covering bipharma’s most comprehensive daily news and updates

Details last updated 02-Aug-2020

Articles written by Amber Tong

Terray Therapeutics unveils game-changing platform for drug discovery

Terray Therapeutics unveils game-changing platform for drug discovery

Endpoints News - 15-Feb-2022

Combining AI with innovative chemistry to tackle the data bottleneck in medicine development

Omega Therapeutics raises $85m for Epigenomic Controllers

Omega Therapeutics raises $85m for Epigenomic Controllers

Endpoints News - 29-Jul-2020

New gene expression therapy for various targets, with clinical trial planned for 2021